Grace Capital’s ResMed RMD Stock Holding History

Grace Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-390	Closed	-$83K	–	245
2020 Q4	$83K	Buy	390 +98	+34%	+$19.5K	0.05%	194
2020 Q3	$50K	Buy	+292	New	+$53.9K	0.04%	206
2019 Q2	–	Sell	-4,930	Closed	-$513K	–	202
2019 Q1	$513K	Sell	4,930 -8,040	-62%	-$830K	0.2%	122
2018 Q4	$1.48M	Sell	12,970 -4,750	-27%	-$509K	0.69%	53
2018 Q3	$2.04M	Buy	+17,720	New	+$1.94M	0.8%	44

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Grace Capital's RMD Position: Q1 2021 in Review

Grace Capital sold out of ResMed (RMD) in Q1 2021, closing a stake of 390 shares — an estimated $83K sold.

Grace Capital first reported a position in RMD in Q3 2018 and held it in 5 quarters. The position peaked at $2.04M in Q3 2018. 662 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

Grace Capital reported no remaining ResMed position as of Q1 2021 after selling out during the quarter.
Grace Capital sold 390 ResMed shares in Q1 2021, an estimated $83K.
Grace Capital first reported a position in ResMed in Q3 2018 and held it in 5 quarters.
Grace Capital's ResMed position peaked at $2.04M in Q3 2018.
662 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on Grace Capital's 13F filing for Q1 2021, filed 6 May 2021.